Deutsche Boerse-NYSE Said to Offer Sale of Liffe Equities for EU Approval

Deutsche Boerse AG (DB1) and NYSE Euronext (NYX) offered to sell their Liffe equities business as part of remedies aimed at alleviating European regulators’ concerns their merger will stifle competition, according to a person familiar with the situation who declined to be identified.

To contact the reporter on this story: Nandini Sukumar in London at

To contact the editor responsible for this story: Andrew Rummer at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.